readthroughSign in
CompanyPRMENasdaqCambridge, MA

Prime Medicine, Inc.

Prime Medicine develops Prime Editing, a gene editing technology for targeted DNA modifications without double-stranded breaks.

SCHEDULE 13D/ANov 13Latest SEC filing
Nov 12Latest story